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Background: A compelling genetic association with hip or knee 
OA of two functional alleles in the aspartic acid (D) repeat of the 
asporin gene ASPN was recently reported in a Japanese popu- 
lation. Allele D13 of the repeat encoded OA-protection whereas 
allele D14 encoded OA-susceptibility. The two alleles mediate dif- 
ferences in the capacity of asporin to inhibit TGFI~ signalling, with 
the D14 allele being a particularly potent inhibitor. This study was 
soon followed by a report from the same group highlighting an as- 
sociation with hip OA of a functional SNP in the core promoter of 
the calmodulin 1 gene CALM1. The T-allele of the SNP encoded 
OA-susceptibility and this was mediated by a reduced expression 
of the gene. 
Aim of study: To assess, by a case-control study, whether the 
ASPN D-repeat or the CALM1 core promoter SNP were also as- 
sociated with OA in UK Caucasians. 
Methods: Our cases were ascertained using the criteria of signs 
and symptoms of OA sufficiently severe to require joint replace- 
ment surgery. They were aged 56 or over. The ASPN D-repeat 
was genotyped in 1247 cases (737 females and 510 males) com- 
prising 904 individuals who had undergone hip replacement, 278 
individuals who had undergone knee replacement and 65 individ- 
uals who had undergone hip and knee replacement. The CALM1 
SNP was genotyped in 920 cases (547 females and 373 males) 
who had undergone hip replacement. Our controls comprised 
752 individuals (393 females and 359 males) with no signs or 
symptoms of joint disease. They were aged 55 or over. Alleles 
and genotypes of the two polymorphisms were tested for asso- 
ciation by chi-square analysis. Our study had > 95% power at 
a significance level of 0.05 to observe an effect comparable to 
those seen in the Japanese reports. 
Results: For ASPN we did observe that the D13 allele was more 
common in the controls and the D14 allele was more common 
in the cases, which complements the Japanese data. However, 
this trend was only significant (P _< 0.05) for males who had un- 
dergone hip replacement (P = 0.016, odds ratio = 1.48, 95% CI 
1.09-2.01) and would not have remained significant if our data 
had been corrected to take account of the large number of com- 
parisons performed. For CALM1 there was no significant differ- 
ence in allele or genotype frequencies between our cases and 
controls and no difference after stratification by sex. 
Conclusions: Our data suggests that neither the ASPN D-repeat 
nor the CALM1 core promoter SNP have a major influence on 
OA susceptibility in Caucasians. Our study does not call in to 
question the veracity of the Japanese reports. Instead it high- 
lights the complex nature of OA genetic susceptibility. Environ- 
mental factors or other genetic factors that are more prevalent in 
the Japanese may influence the extent to which the ASPN and 
CALM10A risks are manifested. 
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Background: We have previously linkage mapped a hip OA sus- 
ceptibility locus to chromosome 6p12.3-q13 with a subsequent 
analysis revealing association (P < 0.05) to markers located 
within intron 1 of the gene encoding bone morphogenetic protein 
5 (BMP5, see abstract by Chapman et al). This protein is a reg- 
ulator of chondrocyte differentiation. The association is within a 
sequence showing conservation between humans and mice. This 
data implies that polymorphism within cis-acting regulatory ele- 
ments of BMP5 may be risk factors for OA. An analysis of the ex- 
pression of BMP5 has revealed allelic differences in BMP5 mRNA 
output in the articular cartilage chondrocytes of a high proportion 
of OA patients (unpublished observations). BMP5 differential al- 
lelic expression (DAE) is therefore common and supports the ex- 
istence of functional polymorphism in the regulatory elements of 
this gene. 
Aim of study: To assess how widespread the phenomenon of 
BMP5 DAE is within the other tissues of an articulating joint. 
Methods: Batteries of tissue samples were collected from pa- 
tients undergoing a total hip (THR, n = 4) ora  total knee (TKR, n = 
3) replacement. For the THRs, the tissues collected were normal 
cartilage (defined as cartilage away from the wear site), abnormal 
cartilage (cartilage near the wear site), ligament, and synovium. 
For the TKRs, the tissues collected were normal cartilage, abnor- 
mal cartilage, ligament, tendon, synovium, meniscus, and fat pad. 
RNA was extracted from each tissue and BMP5 allelic output was 
discerned by reverse transcriptase-PCR followed by single base 
extension in to BMP5 coding SNPs. Differences in allelic output 
were determined by comparing the RNA results to those from 
a genomic DNA sample, which provides the expected 1:1 ratio. 
The Mann-Whitney U test was used to assess whether the allelic 
ratios for the RNA were significantly different from the expected 
ratio. 
Results: For 6 out of the 7 joints analyzed, the cartilage tissues 
showed DAE, with P-values <0.001. The degree of DAE varied 
with the most extreme case being a THR patient in whom the 
two BMP5 alleles showed a 2.7-fold difference in expression. In 
the cartilage DAE cases the abnormal cartilage sample tended 
to show a more severe DAE phenotype than the normal cartilage 
within a joint. For the TKRs, DAE was observed in the meniscus 
and fat pad but at less of a fold difference than the cartilage tis- 
sues. For 4 out of the 7 joints, DAE was observed in the ligament, 
and for TKRs 1 out of 3 showed DAE in tendon. DAE was ob- 
served in synovium for 2 out of 5 of the joints for which synovial 
tissue was collected. 
Conclusions: BMP5 DAE is a common occurrence in many tis- 
sues of an OA joint. The cis-acting variant or variants that are 
driving DAE appear to have tissue specific effects within some 
joints. If BMP5 DAE is a risk factor for OA, as we suspect, then 
this may not be mediated solely by effects on cartilage: effects on 
other tissues of the joint need to be considered. 
Acknowledgements: James Wilkins is a Marshall Scholar. We 
acknowledge the support of Research into Ageing and the Arthri- 
tis Research Campaign. 
